The Latest from Vivalink

Cardiac monitoring is an essential part of vaccine clinical trials.

Why Vaccine Trials Benefit from Continuous Physiological Monitoring

October 14, 2026
Continuous monitoring improves autoimmune disease research, flare detection, and patient safety.

Why Autoimmune Disease Requires Continuous Observation

September 30, 2026
Press Release

New Survey Finds Patients Want Home-Based Cardiac Rehab, While Coverage and Clinical Oversight Drive Participation

September 29, 2026
Continuous monitoring has the power to reshape neurological trials for promising new treatments.

Why Continuous Monitoring Matters for Neurological Trials

September 16, 2026
Discover why cardiac monitoring is an essential part of metabolic disease and weight loss drug clinical trials.

Cardiac Monitoring's Growing Role in Metabolic Disease Drug Trials

September 2, 2026
Wireless wearables are optimizing inpatient monitoring, closing gaps, and supporting nurses.

How Wireless Wearables are Optimizing Inpatient Monitoring

August 19, 2026
How continuous cardiac monitoring is supporting safer chemotherapy treatment.

The Advantages of Cardiac Monitoring in Supporting Chemotherapy

August 5, 2026
The role of cardiac monitoring in COPD care and clinical trials.

The Role of Cardiac Monitoring in COPD Care and Clinical Trials

July 22, 2026
Continuous cardiac monitoring and HRV help measure mental health data.

Using Cardiac Monitoring as a Stress Detector for Mental Health

July 8, 2026
See More

Free Report - Leading Remote Patient Monitoring Vendors by Juniper Research

GET THE REPORT

Free Report - RPM for Clinical Trials by The Everest Group.

GET THE REPORT

logo-light

The Digital Link to Life

51 E Campbell Ave #160, Campbell, CA 95008
Copyright © 2026 VivaLNK, Inc. All Rights Reserved.

Privacy Policy     Vivalink Warranty     eIFU per EU regulation No 207/2012

End User License Agreement      Terms & Conditions     Solution Partners     Developers